Adoptive T-cell therapy for cancer: boutique therapy or treatment modality?
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 23922301.
- Also identified by DOI 10.1158/1078-0432.CCR-13-1367 and PMC identifier 3830944.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Adoptive cellular therapy, involving the ex vivo enrichment and expansion of antigen-specific immune cells for adoptive transfer, has emerged as an increasingly effective modality for the treatment of patients with advanced cancer refractory to conventional therapy.
Medical subject headings
- Adoptive Transfer
- Cell- and Tissue-Based Therapy
- Lymphocytes, Tumor-Infiltrating
- Melanoma